ABSTRACT
Single crystals of U2Mn3Ge and U2Fe3Ge with a Kagome lattice structure were synthesized using a high-temperature self-flux crystal growth method. The physical properties of these crystals were characterized through measurements of resistivity, magnetism, and specific heat. U2Fe3Ge exhibits ferromagnetic ground state and anomalous Hall effect, and U2Mn3Ge demonstrates a complex magnetic structure. Both compounds exhibit large Sommerfeld coefficient, indicating coexistence of heavy Fermion behaviour with magnetism. Our results suggest that this U2TM3Ge (TM = Mn, Fe, Co) family is a promising platform to investigate the interplay of magnetism, Kondo physics and the Kagome lattice.
ABSTRACT
BACKGROUND: Sirtuin 1, a nicotinamide adenine dinucleotide-dependent deacetylase that is highly expressed in the hippocampus and anterior cortex tissues related to Alzheimer's Disease pathology, can cross the blood-brain barrier and is a promising biomarker. METHODS: A 1:1:1 case-control study was conducted and serum fasting blood glucose, triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, SIRT1, IL-6, Aß1-42, T-tau and P-tau-181 levels were evaluated in blood samples of 26 patients form the Alzheimer's Disease group, 26 patients form the mild cognitive impairment group, and 26 individuals form the normal control group. Receiver operator characteristic curves were used to evaluate the diagnostic significance. RESULTS: Serum SIRT1 level was significantly down-regulated in the mild cognitive impairment patients and Alzheimer's Disease patients compared with that in the normal control group (P<0.05). ROC curve analysis demonstrated that SIRT1 was a promising biomarker to distinguish Alzheimer's Disease patients from the mild cognitive impairment patients and the normal control group. In addition, SIRT1 was estimated to perform well in the diagnosis of Alzheimer's Disease ([AUC] = 0.742). CONCLUSIONS: In summary, the present study suggested that serum SIRT1 might be an early promising diagnostic biomarker for Alzheimer's Disease.
